About Catalyst
CPP-109
Our Team
News
Investors
Business Development
Site Map
Links
Contact Us

Catalyst Seeks Development Partners

atalyst is seeking out-licensing partnering opportunities for CPP-109 and its newly-licensed compound, CPP-115, and in-licensing opportunities for prescription pharmaceutical treatments for addiction and obsessive-compulsive disorders.

For further information, please contact:
Jack Weinstein,
Chief Financial Officer
Vice President, Business Development
201-934-4201
jweinstein@catalystpharma.com